TRNT1 and congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome: TRNT1 expression was significantly reduced by 80-90%, similar to levels seen in SIFD patients (6), with no significant differences between cells treated with LPS or Poly (I:C) (Figure 1A).